Bao Shiwei, Yi Mei, Xiang Bo, Chen Pan
NHC Key Laboratory of Carcinogenesis, Hunan Provincial Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, China.
The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, School of Basic Medical Sciences, Central South University, Changsha, 410078, Hunan, China.
Cancer Cell Int. 2024 Apr 27;24(1):150. doi: 10.1186/s12935-024-03336-y.
Triptolide (TPL) is a compound sourced from Tripterygium wilfordii Hook. F., a traditional Chinese medicinal herb recognized for its impressive anti-inflammatory, anti-angiogenic, immunosuppressive, and antitumor qualities. Notwithstanding its favorable attributes, the precise mechanism through which TPL influences tumor cells remains enigmatic. Its toxicity and limited water solubility significantly impede the clinical application of TPL. We offer a comprehensive overview of recent research endeavors aimed at unraveling the antitumor mechanism of TPL in this review. Additionally, we briefly discuss current strategies to effectively manage the challenges associated with TPL in future clinical applications. By compiling this information, we aim to enhance the understanding of the underlying mechanisms involved in TPL and identify potential avenues for further advancement in antitumor therapy.
雷公藤甲素(TPL)是一种从传统中药雷公藤中提取的化合物,雷公藤以其显著的抗炎、抗血管生成、免疫抑制和抗肿瘤特性而闻名。尽管TPL具有这些优良特性,但其影响肿瘤细胞的确切机制仍不清楚。其毒性和有限的水溶性严重阻碍了TPL的临床应用。在本综述中,我们全面概述了旨在阐明TPL抗肿瘤机制的最新研究成果。此外,我们简要讨论了当前在未来临床应用中有效应对TPL相关挑战的策略。通过汇编这些信息,我们旨在加深对TPL潜在机制的理解,并确定抗肿瘤治疗进一步发展的潜在途径。